InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (3 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
3
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the complete record of transactions filed by Brenner Randall B., Executive. Director active across 1 company, notably Paratek Pharmaceuticals, Inc.. Aggregated, 11 disclosures have been logged. Split: 0 buy · 3 sells. Total volume traded: €51k. History available since 27 May 2021. The latest transaction was filed on 8 August 2023 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Brenner Randall B.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations11 total
329,709 sharesCommon StockSEC:0000899243-23-019365:0
67,500 shares0Common StockSEC:0000904454-23-000478:0
15,000 shares0Common StockSEC:0000904454-22-000649:0
11,105 shares@ US$1.9830.7% of flowCommon StockSEC:0000904454-22-000623:0
3,516 shares@ US$3.4718.0% of flowCommon StockSEC:0000904454-22-000528:0
8,500 shares0Common StockSEC:0000904454-22-000506:0
47,727 shares0Common StockSEC:0000904454-22-000425:0
67,500 shares0Common StockSEC:0000904454-22-000264:0
4,479 shares@ US$4.4234.6% of flowCommon StockSEC:0000904454-21-000844:0
21,250 shares0Common StockSEC:0000904454-21-000624:0
28,636 shares0Common StockSEC:0000904454-21-000516:0
11 of 11 declarations
About Brenner Randall B.
Brenner Randall B. is an executive at Paratek Pharmaceuticals, Inc., where the listed role is Chief Development & Regulatory. Across 11 filings in total, the 11 sampled filings run from 2021-06-08 to 2023-09-21, with EUR 50638 in sales and EUR 0 in buys; the modal transaction nature is Attribution.
